Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Vaccine in Healthy Children and Adolescents
NCT01052402Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Dec 2009
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of inactivated Vero cell based whole virus influenza A/H5N1 in Avian Influenza (AI), sponsored by Resilience Government Services. Started Dec 2009; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT01052402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052402.